Multiple endocrine neoplasia

    • The condition is inherited in an autosomal dominant manner
    • arise from the expression of recessive oncogenic mutations, most of which have been isolated.
    • Affected persons may pass on the mutation to their offspring in the germ cell, but for the disease to become evident a somatic mutation must also occur, such as deletion or loss of a normal homologous chromosome.
    • The defect in MEN 1 is in a novel gene (menin) on the long arm of chromo- some 11
      • Menin represses a transcription factor (JunD) and lack of JunD sup- pression leads to decreased apoptosis and oncogenesis.
    • What is the ‘two hit’ hypothesis in MEN Syndrome
      • Patients with the MEN1 gene carry one mutant gene and a wild type gene (i.e. are heterozygous).
      • When the wild type gene undergoes a random somatic mutation during life, this leads to loss of heterozygosity and explains the late onset of tumours at any stage (the ‘two hit’ hypothesis).
    • MEN 2a and 2b are caused by mutations of the RET proto-oncogene on chromosome 10
      • This gene encodes for a transmembrane glycoprotein receptor.
      • For MEN 2a the mutation is in the extracellular domain; for 2b it is in the intracellular domain.



      • Treatment of established tumours in MEN is largely the same as treatment for similar tumours occurring sporadically.
      • In MEN 1 four-gland parathyroidectomy is usually recommended when surgery is needed since all glands are typically involved.
      • However, the essence of management in MEN is annual screening to detect tumours at an early, treatable stage.
      • Screening
        • Screening for type 1
          • Hyperparathyroidism is usually the first manifestation, and serum calcium is the simplest screening test in families with no identified mutation..
      • Screening for type 2
        • Serum calcium levels will easily detect hyperparathyroidism.
        • Medullary carcinoma of thyroid (MCT) with the known presence of the gene defect, total thyroidectomy is recommended in early childhood or as soon as the gene defect is identified.
        • Calcitonin is a useful tumour marker.
        • Phaeochromocytoma metanephrine or catecholamine estimations.

      Multiple Endocrine Neoplasias Basics Made Simple
      This video covers the basics of the MEN syndromes – 1, 2a, and 2b.
      Multiple Endocrine Neoplasia
      Multiple Endocrine Neoplasia Type 1
      Multiple Endocrine
      Syndromes: MEN1
      MEN1 (Wermer Syndrome) is autosomal dominant cancer syndrome associated with Pituitary, Parathyroid, and Pancreatic neoplasms (3Ps). Most commonly, patients have parathyroid adenoma, pituitary microadenoma, and pancreatic or gastro-duodenal NETs (neuroendocrine tumors). Download the handout:
      Multiple Endocrine Neoplasia (MEN 2B)
      Multiple Endocrine Neoplasia (MEN 2B)
      Instructional Tutorial Video
      Multiple Endocrine Neoplasia Syndromes: MEN1 (revised)
      Internal Medicine ABIM Board Exam Review Question: Multiple Endocrine Neoplasia
      This video about multiple endocrine neoplasia is directly out of the Knowmedge ( Internal Medicine Board Review (ABIM exam) questions qVault. Knowmedge is an online test platform for Internists preparing for their ABIM board exam certification or recertification
      Multiple Endocrine Neoplasia 2A & 2B (autosomal dominant ret mutation)
      Multiple, Endocrine, Neoplasia, 2A, 2B, autosomal, dominant, ret, mutation, symptoms, findings, causes, mnemonics, review, what is, video, study, Rapid Review, Clinical presenation, First Aid, for, USMLE, Step 1, images, wiki, define, wikipedia, 2013, videos, exam, prep, easy, What is usmle, mnemonic,